Meiering, Marvin S. https://orcid.org/0000-0002-9747-5015
Weigner, David
Gärtner, Matti https://orcid.org/0000-0002-1185-1789
Carstens, Luisa
Keicher, Christian https://orcid.org/0000-0002-7552-4082
Hertrampf, Rita
Beckmann, Christian F.
Mennes, Maarten
Wunder, Andreas
Weigand, Anne
Grimm, Simone
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 23 May 2024
Revised: 18 September 2024
Accepted: 23 September 2024
First Online: 14 October 2024
Change Date: 3 December 2024
Change Type: Update
Change Details: The original online version of this article was revised: Table 1 and Table 2 in the Article were not numbered correctly. Table 1 should depict the ROI results whereas Table 2 should depict the whole-brain results. The original article has been corrected.
Change Date: 4 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41398-024-03191-5
Competing interests
: This work was funded by Boehringer Ingelheim Pharma GmbH & Co. KG. Simone Grimm has served as a consultant to and received research support from Boehringer Ingelheim Pharma GmbH & Co. KG. Christian Beckmann and Maarten Mennes are employees of SBGneuro contracted to perform the analyses. Andreas Wunder is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. Christian Keicher and Rita Hertrampf are employees of Charité Research Organisation. The authors declare no conflict of interest.
: All methods were performed in accordance with relevant guidelines and regulations. All participants gave written informed consent to participate in the study. The study was approved by the Independent Ethics Committee, Landesamt für Gesundheit und Soziales, and the Federal Institute for Drugs and Medical Devices (BfArM; 4043918). The study is registered at ClinicalTrials.gov (NCT04156035). This research was conducted in accordance with the declaration of Helsinki.